Maternus-Kliniken AG buy krebskrebs
Start price
27.06.23
/
50%
€1.37
Target price
27.06.24
€1.65
Performance (%)
27.01%
End price
28.06.24
€1.74
Summary
This prediction ended on 28.06.24 with a price of €1.74. The prediction had a final performance of 27.01%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Maternus-Kliniken AG | 1.093% | 1.093% | -45.266% |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by krebskrebs for this prediction
In the thread Maternus-Kliniken AG diskutieren
In the thread Trading Maternus-Kliniken AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten